The Food and Drug Administration approved Faxitron's device to identify breast lumps for removal prior to surgery.
Here are three things to know.
1. The Localizer is a wireless radiofrequency identification breast lesion localization system.
2. Clinicians can use the device to implant a mini RFID tag at the site of the breast lump up to 30 days prior to surgery.
3. The system includes a handheld mobile reader clinicians use to detect the tag within the breast.
More articles on supply chain:
Poll: GOP prioritizes lower drug prices over reducing government's role in healthcare
10 most-read supply chain stories in Apri
Supply chain tip of the week: Target services — not supplies — for cost savings